To include your compound in the COVID-19 Resource Center, submit it here.

Verastem raises $32 million in series B

Cancer company Verastem Inc. (Cambridge, Mass.)

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE